Related Experiment Video

Updated: Jun 22, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Child protection outcomes for infants of substance-using mothers: a matched-cohort study

Andrea McGlade1, Robert Ware, Maree Crawford

  • 1Child Advocacy Service, Royal Children's Hospital, Brisbane, Australia. andrea@ausnet.com.au

Pediatrics
|July 1, 2009
PubMed

Insights

Infants born to mothers with substance use issues face significantly higher risks of child abuse and entering foster care. This highlights a critical need for better interagency collaboration to protect these vulnerable children.

Area of Science:

  • Public Health
  • Child Protection
  • Substance Abuse Research

Background:

  • Parental drug use is a significant public health concern, affecting up to 80% of referrals to Australian child protection agencies.
  • There is a lack of data on child protection outcomes for infants of substance-using parents in Australia.
  • No prior comparisons have been made between infants of substance-using and non-substance-using parents in this context.

Purpose of the Study:

  • To assess and quantify the differences in substantiated abuse between infants of substance-using mothers and infants of non-substance-using mothers.
  • To compare child protection outcomes for these two groups of infants in Brisbane.
  • To provide data on the risks associated with maternal drug use for child protection.

Main Methods:

  • A cohort study comparing mothers who disclosed opiate, amphetamine, or methadone use (2000-2003) with matched non-substance-using mothers.
  • Infants were linked to the Department of Child Safety Child Protection Information System database.
  • Child protection outcomes, including substantiated notifications and foster care entry, were compared.

Main Results:

  • Infants of substance-using mothers were significantly more likely to experience substantiated harm (HR 13.3) and enter foster care (HR 13.3).
  • Infants of mothers using illicit drugs showed higher rates of substantiated harm and foster care entry compared to those compliant with methadone programs.
  • The study included 119 infants of substance-using mothers and 238 matched controls.

Conclusions:

  • Infants of substance-using mothers experience substantially poorer child protection outcomes.
  • There is a clear association between maternal drug use and increased risk of child abuse.
  • Enhanced interagency collaboration is essential to mitigate these risks and improve child safety.
Abstract

More Related Videos

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Related Concept Videos

Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...